BSE filing, NSE: APOLLOHOSP. Summary written from the filing by ALFA Finder's alert engine.
Apollo Hospitals Enterprise Ltd: key numbers
- Share price
- ₹8,137.00
- Market cap
- ₹1,16,998 Cr
- Revenue (annual)
- ₹25,228 Cr
- Net profit (annual)
- ₹1,942 Cr
- P/E (TTM)
- 56.0×Sector 52.0×
- Promoter holding
- 28.02%+0.00% QoQ
- FII holding
- 43.19%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Apollo Hospitals Enterprise Ltd
All →Apollo Hospitals Enterprise Board Meeting Date
Apollo Hospitals will hold a board meeting on 04 Nov 2026 to consider Q1 FY27 financial results. No financial figures are disclosed in this advance intimation.
Apollo Hospitals Enterprise Other Announcement
Apollo Hospitals Enterprise Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, as per regulatory requirements.
Apollo Hospitals Enterprise Share Pledge
Apollo Hospitals Enterprise promoter K Vishweshwar Reddy created a pledge on 200,000 equity shares worth ₹177.78 Crore. This transaction reflects a change in promoter encumbrance status.
- Value
- ₹177.8 Cr
Apollo Hospitals Enterprise Annual General Meeting
Apollo Hospitals Enterprise Limited conducted its 45th Annual General Meeting on August 25, 2026. The proceedings covered routine items and resolutions, including NCD issuance approval.
Apollo Hospitals Enterprise Earnings Call Transcript: Key Takeaways
Apollo started FY27 with 21% revenue growth, driven by a 22% surge in Healthcare Services and improved digital health economics.
- Call
- Guides 20% growth
Apollo Hospitals Enterprise Investor Presentation: Key Takeaways
Apollo Hospitals reported strong Q1FY27 consolidated revenue growth of 21% YoY to ₹70,435 mio, driven by robust healthcare services and diagnostics performance alongside narrowing digital cash losses.
Other merger & restructuring announcements
All →Quint Digital Merger & Restructuring
Quint Digital's board approved a Rule 10b5-1 trading plan and the incorporation of a wholly owned overseas subsidiary. No investment amount was disclosed.
Hexaware Technologies Merger & Restructuring
Hexaware Technologies approved a slump sale of its step-down subsidiary Tech SMC Square India to Tech SMC Squared (GCC) India, a related-party deal. Consideration is cash, yet to be set by a registered valuer.
- Execution
- Expected completion by 30 June 2027; agreement date stated as 1 December 2026
Emkay Global Financial Services Merger & Restructuring Worth ₹2.75 Cr
Emkay Global agreed to sell its Wealth Management Business to a step-down subsidiary, Emkay Wealth Advisory, for Rs. 2.75 Crore cash. Completion is expected by 26 January 2027.
- Value
- ₹2.75 Cr
- Execution
- Completion expected by 26 January 2027
TVS Holdings Merger & Restructuring
TVS Holdings forwarded TVS Motor's board outcome of October 28, 2026 approving acquisition of Harita ARC and a composite scheme of amalgamation and demerger. The scheme is subject to stock exchange, SEBI, NCLT and shareholder approvals.
Emkay Global Financial Services Merger & Restructuring Worth ₹30 Cr
Emkay Global approved transferring two subsidiaries to new subsidiary ECPL and slump-selling its wealth business. Up to Rs.30 Crore rights investment in ECPL was also approved.
- Value
- ₹30.00 Cr
- Execution
- Divestment completion expected within 90 days of SPA execution, subject to regulatory approvals
Fortis Healthcare Merger & Restructuring Worth ₹277 Cr
Fortis subsidiary International Hospital acquired Suguna Ramaiah Hospitals' business, operations, land and building for Rs 277 Crore cash. The deal was consummated today, strengthening Bengaluru presence.
- Value
- ₹277.0 Cr